Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRPF1 | P55201 | 11/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.40 |
| ▸ | BRD1 | O95696 | 4/20 | 0.38 |
| ▸ | BRD4 | O60885 | 3/20 | 0.38 |
| ▸ | BRD9 | Q9H8M2 | 2/20 | 0.38 |
| ▸ | BRPF3 | Q9ULD4 | 2/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | ECE1 | P42892 | 1/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.36 |
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20344757 | 0.86 | BRPF1 (0.50) | BRPF1HDAC8BRD1BRD4BRD9 | |
| SCHEMBL20616475 | 0.85 | BRPF1 (0.38) | BRPF1HDAC8BRD4HDAC1HDAC6 | |
| SCHEMBL20616477 | 0.84 | BRPF1 (0.55) | BRPF1HDAC8BRD1BRD4BRD9 | |
| SCHEMBL20344727 | 0.84 | BRPF1 (0.52) | BRPF1HDAC8BRD1BRD4BRD9 | |
| SCHEMBL22756346 | 0.83 | BRPF1 (0.54) | BRPF1HDAC8BRD1BRD4BRD9 | |
| SCHEMBL20344777 | 0.82 | BRPF1 (0.50) | BRPF1HDAC8BRD1BRD4BRD9 | |
| SCHEMBL20344753 | 0.79 | BRPF1 (0.35) | BRPF1PTGDR2MAPT | |
| SCHEMBL20344719 | 0.78 | BRPF1 (0.47) | BRPF1HDAC8BRD1BRD4BRD9 | |
| SCHEMBL17979387 | 0.75 | MAPT (0.45) | BRPF1MAPT | |
| SCHEMBL20344748 | 0.73 | BRD4 (0.41) | HDAC8BRD4HDAC1HDAC6MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3342766-B1 | SMALL MOLECULE COMPOUND FOR ENHANCING PLANT STRESS RESISTANCE | CAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES (CN) | 2020-12-09 | — | — | EP | disclosed |
| US-10842151-B2 | Small molecule compound for enhancing plant stress resistance | CAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES (CN) | 2020-11-24 | — | — | US | disclosed |
| EP-3342766-A1 | SMALL MOLECULE COMPOUND FOR ENHANCING PLANT STRESS RESISTANCE | Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (CN) | 2018-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10842151-B2 | Small molecule compound for enhancing plant stress resistance | CYP4F11, RICTOR, MYB | BRPF1 1596/4885HDAC8 2101/4885BRD1 1074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.